|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0178655,
umls-concept:C0205179,
umls-concept:C0205195,
umls-concept:C0332293,
umls-concept:C0681842,
umls-concept:C0684249,
umls-concept:C1122962,
umls-concept:C1171362,
umls-concept:C1274040,
umls-concept:C1414313,
umls-concept:C1516213
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2007-3-28
|
|
pubmed:abstractText |
Biological markers for optimal selection of patient to epidermal growth factor receptor (EGFR)-targeted therapies are not established in advanced non-small-cell lung cancer (NSCLC).
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0923-7534
|
|
pubmed:author |
pubmed-author:BemisLL,
pubmed-author:BunnP APAJr,
pubmed-author:CappuzzoFF,
pubmed-author:ChanskyKK,
pubmed-author:CrinoLL,
pubmed-author:DziadziuszkoRR,
pubmed-author:FranklinW AWA,
pubmed-author:GandaraD RDR,
pubmed-author:GazdarA FAF,
pubmed-author:GumerlockPP,
pubmed-author:HirschF RFR,
pubmed-author:McCoyJJ,
pubmed-author:Varella-GarciaMM,
pubmed-author:WestHH,
pubmed-author:XavierA CAC
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
18
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
752-60
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:17317677-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:17317677-Female,
pubmed-meshheading:17317677-Gene Dosage,
pubmed-meshheading:17317677-Genes, erbB-2,
pubmed-meshheading:17317677-Genes, ras,
pubmed-meshheading:17317677-Humans,
pubmed-meshheading:17317677-Immunohistochemistry,
pubmed-meshheading:17317677-In Situ Hybridization, Fluorescence,
pubmed-meshheading:17317677-Lung Neoplasms,
pubmed-meshheading:17317677-Male,
pubmed-meshheading:17317677-Mutation,
pubmed-meshheading:17317677-Quinazolines,
pubmed-meshheading:17317677-Receptor, Epidermal Growth Factor,
pubmed-meshheading:17317677-Treatment Outcome
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Combination of EGFR gene copy number and protein expression predicts outcome for advanced non-small-cell lung cancer patients treated with gefitinib.
|
|
pubmed:affiliation |
Division of Medical Oncology, Department of Medicine, University of Colorado Health Sciences Center and Cancer Center, Aurora, CO 80010, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|
